APA (7th ed.) Citation

EJ, T., JC, C., LM, G., J, S., C, T., G, A., . . . ER, T. (2022). Mitochondrial Dysfunction Is a Driver of SP-2509 Drug Resistance in Ewing Sarcoma. Molecular cancer research : MCR, 20(7), 1035. https://doi.org/10.1158/1541-7786.MCR-22-0027

Chicago Style (17th ed.) Citation

EJ, Tokarsky, et al. "Mitochondrial Dysfunction Is a Driver of SP-2509 Drug Resistance in Ewing Sarcoma." Molecular Cancer Research : MCR 20, no. 7 (2022): 1035. https://doi.org/10.1158/1541-7786.MCR-22-0027.

MLA (9th ed.) Citation

EJ, Tokarsky, et al. "Mitochondrial Dysfunction Is a Driver of SP-2509 Drug Resistance in Ewing Sarcoma." Molecular Cancer Research : MCR, vol. 20, no. 7, 2022, p. 1035, https://doi.org/10.1158/1541-7786.MCR-22-0027.